UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Therapy for High-Grade, Uterus-Limited Leiomyosarcoma: Results of a Phase 2 Trial (SARC 005)

Cancer, 2013-04, Vol.119 (8), p.1555-1561

2013

Volltextzugriff (PDF)

Practical Bayesian adaptive randomisation in clinical trials

European journal of cancer (1990), 2007-03, Vol.43 (5), p.859-866

2007

Volltextzugriff (PDF)

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3148-3153

2009

Volltextzugriff (PDF)

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

Clinical cancer research, 2010-10, Vol.16 (19), p.4884-4891

2010

Volltextzugriff (PDF)

Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

The oncologist (Dayton, Ohio), 2012-03, Vol.17 (3), p.321-e329

2012

Volltextzugriff (PDF)

A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)

Contemporary clinical trials communications, 2023-04, Vol.32, p.101061-101061, Article 101061

2023

Volltextzugriff (PDF)

Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality

Clinical trials (London, England), 2009-02, Vol.6 (1), p.28-41

2009

Volltextzugriff (PDF)

Bayesian adaptive model selection for optimizing group sequential clinical trials

Statistics in medicine, 2008-11, Vol.27 (27), p.5586-5604

2008

Volltextzugriff (PDF)

A simulation study of outcome adaptive randomization in multi-arm clinical trials

Clinical trials (London, England), 2017-10, Vol.14 (5), p.432-440

2017

Volltextzugriff (PDF)

A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients

Leukemia, 2013-04, Vol.27 (4), p.861-865

2013

Volltextzugriff (PDF)

Accounting for patient heterogeneity in phase II clinical trials

Statistics in medicine, 2008-07, Vol.27 (15), p.2802-2815

2008

Volltextzugriff (PDF)

Adaptive Design: Results of 2012 Survey on Perception and Use

Therapeutic innovation & regulatory science, 2014-07, Vol.48 (4), p.473-481

2014

Volltextzugriff (PDF)

Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study

Journal of clinical oncology, 2011-01, Vol.29 (3), p.294-302

2011

Volltextzugriff (PDF)

SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

Cancer, 2016-03, Vol.122 (6), p.868-874

2016

Volltextzugriff (PDF)

Who wants to go first? A simulation study of accrual in a stand-alone trial versus starting a platform trial

Contemporary clinical trials, 2022-12, Vol.123, p.107000-107000, Article 107000

2022

Volltextzugriff (PDF)

OPTIMAL COMPOSITE COGNITIVE ENDPOINTS FOR PRE-SYMPTOMATIC ALZHEIMER’S DISEASE: CONSIDERATIONS IN BRIDGING ACROSS STUDIES

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P820-P820

2016

Volltextzugriff (PDF)

P3‐008: Optimal Composite Cognitive Endpoints for PRE‐Symptomatic Alzheimer’s Disease: Considerations in Bridging Across Studies

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_16), p.P820-P820

2016

Volltextzugriff (PDF)

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials

JAMA network open, 2022-07, Vol.5 (7), p.e2221140-e2221140

2022

Volltextzugriff (PDF)

Bayesian model averaging in meta-analysis: Authors' response

Clinical trials (London, England), 2009-02, Vol.6 (1), p.50-51

2009

Volltextzugriff (PDF)

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

Cancer, 2013-04, Vol.119 (8), p.1555-1561

2013

Volltextzugriff (PDF)

Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments

Statistics in medicine, 2005-07, Vol.24 (13), p.1947-1964

2005

Volltextzugriff (PDF)

Adaptive Design: Results of 2012 Survey on Perception and Use

Therapeutic innovation & regulatory science, 2014-07, Vol.48 (4), p.473-481

2014

Volltextzugriff (PDF)

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

Statistics in medicine, 2003-03, Vol.22 (5), p.763-780

2003

Volltextzugriff (PDF)

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2755-2763

2007

Volltextzugriff (PDF)

Continuous Bayesian adaptive randomization based on event times with covariates

Statistics in medicine, 2006-01, Vol.25 (1), p.55-70

2006

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Therapy for High-Grade, Uterus-Limited Leiomyosarcoma: Results of a Phase 2 Trial (SARC 005)

Practical Bayesian adaptive randomisation in clinical trials

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)

Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality

Bayesian adaptive model selection for optimizing group sequential clinical trials

A simulation study of outcome adaptive randomization in multi-arm clinical trials

A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients

Accounting for patient heterogeneity in phase II clinical trials

Adaptive Design: Results of 2012 Survey on Perception and Use

Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study

SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

Who wants to go first? A simulation study of accrual in a stand-alone trial versus starting a platform trial

OPTIMAL COMPOSITE COGNITIVE ENDPOINTS FOR PRE-SYMPTOMATIC ALZHEIMER’S DISEASE: CONSIDERATIONS IN BRIDGING ACROSS STUDIES

P3‐008: Optimal Composite Cognitive Endpoints for PRE‐Symptomatic Alzheimer’s Disease: Considerations in Bridging Across Studies

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials

Bayesian model averaging in meta-analysis: Authors' response

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments

Adaptive Design: Results of 2012 Survey on Perception and Use

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Continuous Bayesian adaptive randomization based on event times with covariates

Suchergebnisse filtern